key: cord-0278519-djt5p3gp
authors: Malone, Brandon F.; Perry, Jason K.; Olinares, Paul Dominic B.; Chen, James; Appelby, Todd K.; Feng, Joy Y.; Bilello, John P.; Ng, Honkit; Sotiris, Johanna; Ebrahim, Mark; Chua, Eugene Y.D.; Mendez, Joshua H.; Eng, Ed T.; Landick, Robert; Chait, Brian T.; Campbell, Elizabeth A.; Darst, Seth A.
title: Structural basis for substrate selection by the SARS-CoV-2 replicase
date: 2022-05-20
journal: bioRxiv
DOI: 10.1101/2022.05.20.492815
sha: b74d5f863889cc3c1ebe9e74fb11bf0352101ea5
doc_id: 278519
cord_uid: djt5p3gp

The SARS-CoV-2 RNA-dependent RNA polymerase coordinates viral RNA synthesis as part of an assembly known as the replication-transcription complex (RTC)1. Accordingly, the RTC is a target for clinically approved antiviral nucleoside analogs, including remdesivir2. Faithful synthesis of viral RNAs by the RTC requires recognition of the correct nucleotide triphosphate (NTP) for incorporation into the nascent RNA. To be effective inhibitors, antiviral nucleoside analogs must compete with the natural NTPs for incorporation. How the SARS-CoV-2 RTC discriminates between the natural NTPs, and how antiviral nucleoside analogs compete, has not been discerned in detail. Here, we use cryo-electron microscopy to visualize the RTC bound to each of the natural NTPs in states poised for incorporation. Furthermore, we investigate the RTC with the active metabolite of remdesivir, remdesivir triphosphate (RDV-TP), highlighting the structural basis for the selective incorporation of RDV-TP over its natural counterpart ATP3,4. Our results elucidate the suite of interactions required for NTP recognition, informing the rational design of antivirals. Our analysis also yields insights into nucleotide recognition by the nsp12 NiRAN, an enigmatic catalytic domain essential for viral propagation5. The NiRAN selectively binds GTP, strengthening proposals for the role of this domain in the formation of the 5’ RNA cap6.

and overwhelm healthcare systems worldwide. Given the urgency of stymieing infection 55 and mitigating disease morbidity, a concerted research effort has begun to elucidate the 56 molecular details of the viral lifecycle and to design therapeutics to disrupt it 1 . The viral 57

RNA-dependent RNA polymerase (RdRp, encoded by non-structural protein 12, or 58 nsp12) functions as part of the holo-RdRp (comprising the RdRp and auxiliary proteins 59 nsp7 and nsp8 as a heterotetramer nsp7/nsp82/nsp12) in a replication-transcription 60 complex (holo-RdRp + RNA, or RTC) to direct all viral RNA synthesis in conjunction with 61 a coterie of viral nucleic acid processing enzymes. In less than two years, targeting the 62 RTC by the antivirals remdesivir (RDV) and molnupiravir has become the staple of 63 clinical care 2,7 . This clinical success underscores the importance of the RTC as a 64

pharmacological target and incentivizes the design of more efficacious nucleotide 65

analogues for the treatment of COVID-19. Furthermore, due to the highly conserved 66 nature of the coronavirus RdRp active site 8 , nucleotide analogue inhibitors of the RTC 67 are excellent candidates for pan-viral inhibitors that would be effective against emerging 68 variants and may be repurposed to tackle future pathogenic coronaviruses that could 69 arise. 70

Biochemical and single-molecule experiments have characterized the RNA 71 synthesis activity of the SARS-CoV-2 RTC, its selectivity for a wide range of nucleotide 72

analogs, and their effects on RNA synthesis 3, 4, 9, 10 . These investigations yielded insights 73

into the ability of the RTC to discriminate between natural NTPs and related antiviral 74

analogs. Studies of remdesivir (RDV) revealed that the active metabolite of RDV, 75

RDV triphosphate (RDV-TP), possesses enhanced selectivity for incorporation into 76 nascent RNA over its natural counterpart, ATP 3,4 . Rapid, competitive incorporation is 77 likely a critical facet of the clinical effectiveness of RDV. However, the structural basis 78 for NTP recognition and RDV-TP selectivity remains unknown, necessitating structural 79 examinations of stalled RTC ternary complexes with incoming NTP substrates and 80 catalytic metal ions poised for catalysis (Michaelis or pre-incorporation complexes) (Fig.  81 1a). 82

Stepwise nucleotide incorporation necessitates transferring the 3'-end of the 83 product-RNA (p-RNA) to the post-translocated site, allowing binding of the incoming 84 NTP substrate along with two catalytic metal ions in the active-site cleft (Fig. 1a ) 11,12,13 . 85 In the subsequent catalytic step(s), the geometry of correct Watson-Crick base pairing 86

of the incoming NTP with the template-RNA (t-RNA) base closes the active site. This 87 conformational change promotes nucleophilic attack of the p-RNA 3'-OH on the NTP α-88

phosphate, releasing a pyrophosphate in a SN2 condensation reaction 11 Guided by previous mechanistic work on nucleic acid polymerases, we investigated a 105 battery of chemical strategies to block incorporation after substrate binding. These 106 approaches included using nucleotide diphosphate (NDP) substrates 13 , alternative 107 metal co-factors (such as Ca 2+ ) 21 , α-β non-hydrolysable nucleotide analogues 22 , and 108

3'-deoxy p-RNA scaffolds. Although the use of NDP substrates trapped the hepatitis C 109 virus (HCV) RdRp recognition complex 13 , the SARS-CoV-2 RTC efficiently incorporated 110 GDP, less efficiently ADP, and to a minor extent RDV-diphosphate (RDV-DP) 111

(Extended Data Fig. 6 , see also 23 ). The ability of the SARS-CoV-2 RTC to incorporate 112

NDPs reflects the relative promiscuity of the RdRp active site, which also retained RNA 113 synthesis activity in the presence of both Ca 2+ and α-β-imino analogues (Extended Data 114 Fig. 6e ). However, RTC synthesis activity was fully ablated with the incorporation of a 115

3'-deoxy nucleotide into the p-RNA, leading us to utilize this approach to visualize the 116 RTC pre-incorporation complexes (Extended Data Fig. 6g ). 117

To validate the effectiveness of using 3'-deoxy RNA scaffolds, we used native 118 mass spectrometry (nMS) to probe for the extension of the primer by one base or the 119 formation of a stalled ternary complex (Fig 1b, c, Extended Data Fig. 7) in the presence 120 of various NTPs. In the event of nucleotide incorporation, we expected a mass-shift 121

corresponding to NMP addition, whereas non-covalently bound (unincorporated) 122 substrates would either dissociate or yield a mass-shift corresponding to the NTP and 123

bound metal ions. For the control scaffolds containing a 3'-OH, near complete p-RNA 124 extension by a single NMP occurred (Fig. 1b) . In the presence of p-RNA strands lacking 125 a 3'-OH, no incorporation of the next nucleotide (ATP, RDV-TP, or GTP) was observed, 126

confirming the suitability of this strategy for trapping pre-incorporation complexes (Fig.  127 1c). In the pre-incorporation complexes, we observed peaks corresponding to the RTC 128

with the incoming Mg-NTP (ATP, RDV-TP, or GTP) with the relative peak intensity in 129 the order of GTP > RDV-TP > ATP (Fig. 1c) . 130 131

Having identified a strategy to capture substrate-bound RTCs stalled in a pre-133

incorporation state, we prepared cryo-EM samples of RTCs with each of the natural 134 nucleotides, ATP, CTP, GTP, UTP, or with RDV-TP (Extended Data Fig. 1 to interact with the NTP γ-phosphate (Fig. 2d) . 160

The detailed interactions of nsp12 residues with the four natural NTP substrates 161

were essentially identical except for conserved basic residues of motif F. K545 (motif F) 162

displays selective interactions with the incoming NTPs, forming a H-bond with carbonyl 163 oxygens of UTP (C4) and GTP (C6), interactions that are precluded by the amino group 164 at these positions in the ATP, RDV-TP, or CTP bases (Extended Data Fig. 9 ). The cryo-165

EM densities also suggest that the side chains of K551 and R555 are dynamic, 166 accessing multiple conformations in each structure. K551 primarily interacts with the -167 phosphate of the CTP and RDV-TP substrates, but weak density indicates disorder in 168 the other structures. In the +ATP and +RDV-TP structures, R555 predominantly forms a 169

pi-pi stacking interaction with the NTP substrate base. This differs from the predominant 170 conformation in the +CTP, +GTP, and +UTP structures where the side chain of R555 171

forms a H-bond with the -phosphate oxygens of the NTP substrate (Fig. 3 , Extended 172 data Fig. 9 ). In either state, R555 buttresses the incoming nucleotide, arranging the 173 active site for catalysis. We speculate that the observed R555 stacking interaction may 174 first promote the formation of a canonical Watson-Crick base pair by stabilizing the 175 nucleobase opposite the template base, then reorient to interact with the nucleotide -176 phosphate to promote subsequent catalysis by reinforcing the correct geometry of the 177 pyrophosphate leaving group, roles that may be conserved across RdRps such as HCV 178

RdRp 25 . 179

The structural observation of SARS-CoV-2 RdRp motif A closure resembles a 180 similar motion of motif A observed in substrate-bound RdRp complexes of polio virus 181

and HCV 12, 13 , illustrating the universal nature of the RdRp palm closure step during 182 NTP recognition. Although the palm-mediated active site closure is well-documented, 183

our results indicate that the structural plasticity of positively charged residues in motif F 184 (K545, K551, R553, and R555) in the fingers domain helps orient the NTP substrate for 185 catalysis through interactions with both the nucleobase and triphosphate moieties. We 186 note that these residues are invariant across the major coronavirus clades and GISAID 187 database of patient SARS-CoV-2 sequences (Extended Data Fig. 8 

RDV-TP has been characterized in biochemical studies to possess an almost threefold 194 greater selectivity for incorporation into elongating RNA compared to ATP 3, 4 , a property 195 which is thought to improve its ability to inhibit RNA synthesis. In our structures, both 196

nucleotides are observed base-paired to the cognate t-RNA U; the two nucleotides 197

superimpose with a root-mean-square-deviation (RMSD) of 0.34 Å over 32 common 198

atoms. The key difference between RDV-TP and ATP is the 1'-cyano moiety on the 199 RDV-TP ribose (Fig. 3a) , which juts into a hydrophilic pocket formed by residues T687, 200 N691 (motif B), and S759 (motif C) (Fig. 3c) , creating a network of polar interactions 201 (Fig. 3c ). In the highest resolution cryo-EM maps (+CTP and +GTP; Extended Data 202 Table 1 ), we observed a stably bound water molecule occupying the hydrophilic pocket 203

in the absence of the RDV-TP cyano-group (compare Fig. 3c to 3d, e), suggesting that 204 the enhanced affinity (lower Km) for RDV-TP over ATP 3, 4 may be attributed to both an 205 entropic effect through release of the bound water and an enthalpic effect through 206 formation of new polar interactions between RDV-TP and the surrounding polar 207 residues. A recent study reports that SARS-CoV-2 acquired phenotypic resistance to 208

RDV through an nsp12-S759A substitution following serial passage in cell culture 27 , 209 indicating that binding of the RDV-TP 1'-cyano group in this hydrophilic pocket is an 210 important facet of RDV susceptibility. 211 and makes few, if any, protein contacts. ADP has not been shown to serve as a 223

substrate for the NiRAN enzymatic activity, and the GDP was bound along with an N-224

terminally modified (and resultingly inactive) nsp9 29 , so the relevance of these 225 nucleotide poses is unclear. In another study, the diphosphate form of the GTP analog 226

AT-9010 is seen bound to the NiRAN in a 'base-in' pose 19 , with the phosphates 227

occupying the same positions as the phosphates in the 'base-out' pose but flipped, and 228

with the guanine base bound in a tight pocket internal to the NiRAN (Extended Data 229 Fig. 10 ). 230

In our cryo-EM structures of the RTC with each of the natural NTPs and RDV-TP 231

(Extended Data Table 1 ), only GTP was observed stably and specifically bound in the 232

NiRAN active site. The cryo-EM density supports the presence of GTP (and not GDP) in 233

the NiRAN (Fig. 4) . The GTP is bound in the 'base-in' pose similar to the diphosphate 234 form of AT-9010 19 , with the base buried in an apparently guanine-specific pocket that 235 extends into the core of the NiRAN fold, enabling it to make key contacts with 236 hydrophilic residues that line the pocket interior. A central element to this recognition is 237

interactions mediated by R55 and Y217, two conserved residues across the -and -238 coronavirus clades, which provide base specificity for guanosine ( Fig. 4 

NiRAN pocket is sterically incompatible with the bound guanine base; GTP association 240 is mediated by an induced fit mechanism that involves expansion of the active-site 241 pocket to accommodate the guanosine base ( Fig. 4e) . 242

A recent preprint proposes that the NiRAN mediates two successive steps in the 243 viral RNA capping pathway that initially entails transfer of the nascent RNA 5'-end to the 244 amino terminus of nsp9, forming a covalent RNA-protein intermediate in a process 245

termed RNAylation 6 . A successive polyribonucleotidyltransferase (PRNTase) reaction 246 utilizes the RNAylated nsp9 as a substrate and transfers the bound RNA to GDP/GTP 247 to produce the cap structure, GpppN-RNA. The PRNTase activity strictly utilizes GDP or 248

GTP. Although the authors report slightly higher PRNTase activity when GDP is the 249 substrate, GTP may be the more likely physiological substrate given that concentrations 250 of GTP are much higher than GDP in the cellular milieu 31 . Our results indicate that the 251 NiRAN uniquely recognizes GTP (but not other NTPs), explaining the base specificity 252

observed for the PRNTase activity. 253 254 255

Antiviral nucleotide analogues are highly effective and versatile therapeutics that can be 257 adapted to treat novel coronaviral borne diseases as they emerge. Their suitability for 258

repurposing is exemplified by the use of RDV and molnupiravir for the treatment of 259 COVID-19, two analogues that were initially developed as therapeutics against 260

Ebola virus 32 and influenza virus 33 . Repurposing efforts rely on the conserved active 261 site of the RdRp, which has not been observed to mutate as readily as other COVID-19 262 therapeutic targets such as the Spike protein (Extended Data Fig. 8 ). While active site 263

residues are highly conserved across RdRp-encoding viruses, subtle differences can 264

alter the incorporation selectivity of a nucleotide analogue more than 100-fold 4 265

highlighting the importance of mechanistic investigations of RdRps across the viral 266 realm. 267

To probe the mechanism of nucleotide recognition by the SARS-CoV-2 RdRp, 268

we determined structures of stalled RdRp complexes containing an RNA primer-269 template, incoming nucleotide substrates or the antiviral RDV-TP, and catalytic metal 270

ions. Structural views of the RTC with each of the respective nucleotides illustrate how 271

the RdRp structurally adapts to proper Watson-Crick base pairing geometry, closing in 272

around the t-RNA/NTP base pair to facilitate catalytic Mg 2+ coordination and in-line 273

attack of the p-RNA 3'-OH on the NTP -phosphate. 274

Through visualizing these structures, we ascertained that the enhanced 275 selectivity for RDV, which primarily materializes biochemically as an effect on Km, is 276 mediated by the accommodation of its 1'-cyano group in a conserved hydrophilic pocket 277 near the RdRp active site (Fig. 3 ). This same RdRp active site pocket harbors an 278 ordered water molecule in the +CTP and +GTP structures (Fig. 3) ; the bound water is 279 likely present in the +ATP and +UTP complexes as well but not visualized due to limited 280 resolution (Extended Data Figs. 2, 3). Mutations that alter the hydrophilicity of this 281 pocket give rise to RDV resistance 27 and are naturally found in viral families that exhibit 282 reduced sensitivity to RDV 4 . Critically, structural insights into NTP recognition could be 283 exploited in the design of nucleotide analogues as part of structure-based drug design 284

programs that aim to target the coronavirus RdRp. Our studies also shed light on the 285 presence of a guanosine-specific pocket in the essential NiRAN domain, supporting 286

proposals that the NiRAN is involved in the production of capped mRNAs as well as 287 further detailing this pocket as a therapeutic target. The Structural Basis for RNA Specificity and Ca2+ Inhibition of an RNA-Dependent RNA 367

Polymerase. No statistical methods were used to predetermine sample size. The experiments were 541 not randomized, and the investigators were not blinded to allocation during experiments 542 and outcome assessment. 543 544

SARS-CoV-2 nsp12 was expressed as previously described 34 and purified as follows. 546

Briefly, a pQE-30/pcl-ts ind+ plasmid containing a His6-SUMO SARS-CoV-2 nsp12 and 547 untagged nsp7 & 8 (Addgene #160540) was transformed into E. coli BL21 cells 548

(Agilent). Cells were grown and protein expression was induced by the addition of 0.2 549 mM isopropyl β-d-1-thiogalactopyranoside (IPTG), 10 ng/mL tetracycline and 50 ug/mL 550 nalidixic acid. Cells were collected and lysed in a French press (Avestin). The lysate 551

was cleared by centrifugation and purified on a HiTrap Heparin HP column (Cytiva). The 552

fractions containing nsp12 were loaded onto a HisTrap HP column (Cytiva) for further 553 purification. Eluted nsp12 was dialyzed, cleaved with His6-Ulp1 SUMO protease, and 554

passed through a HisTrap HP column to remove the SUMO protease. Flow-through was 555 collected, concentrated by centrifugal filtration (Amicon), and loaded on a Superdex 200 556

Hiload 16/600 (Cytiva). Glycerol was added to the purified nsp12, aliquoted, flash-frozen 557 with liquid N2, and stored at -80°C. 558 SARS-CoV-2 nsp7/8 was expressed and purified as described 14 . Briefly, the 559 pCDFDuet-1 plasmid containing His6 SARS-CoV-2 nsp7/8 (Addgene #159092) was 560

transformed into E. coli BL21 (DE3). Cells were grown and protein expression was 561

induced by the addition of IPTG. Cells were collected and lysed in a French press 562 (Avestin). The lysate was cleared by centrifugation and purified on a HisTrap HP 563 column (Cytiva). Eluted nsp7/8 was dialyzed, cleaved with His6-Prescission Protease to 564 cleave His6 tag, and then passed through a HisTrap HP column to remove the protease 565 (Cytiva). Flow-through was collected, concentrated by centrifugal filtration (Amicon), and 566 loaded onto a Superdex 75 Hiload 16/600 (Cytiva). Glycerol was added to the purified 567 nsp7/8, aliquoted, flash-frozen with liquid N2, and stored at -80°C. 568

Cryo-EM samples of SARS-CoV-2 RTC were prepared as previously described 14, 17 . 570

Briefly, purified nsp12 and nsp7/8 were concentrated, mixed in a 1:3 molar ratio, and 571 incubated for 20 min at 22 o C. An annealed RNA scaffold (Horizon Discovery, Ltd.) was 572 added to the nsp7/8/12 complex and incubated for 10 min at 30 o C. Sample was buffer 573 exchanged into cryo-EM buffer [20 mM HEPES pH 8.0, 100 mM K-Acetate, 5 mM 574

MgCl2, 2 mM DTT] and further incubated for 20 min at 30 o C. The sample was purified 575 over a Superose 6 Increase 10/300 GL column (Cytiva) in cryo-EM buffer. The peak 576

corresponding to nsp7/8/12/RNA complex was pooled and concentrated by centrifugal 577 filtration (Amicon). 578 579 Cryo-EM grid preparation. Prior to grid freezing, beta-octyl glucoside (β-OG) was 580 added to the sample (0.07 % w/v final). The final buffer condition for the cryo-EM 581 sample was 20 mM HEPES pH 8.0, 100 mM K-Acetate, 5 mM MgCl2, 2 mM DTT, 582 0.07% (w/v) β-OG with 300 μM final of the respective NTP added immediately before 583

freezing. C-flat holey carbon grids (CF-1.2/1.3-4Au, EMS) were glow-discharged for 20 584 seconds prior to the application of 3.5 μL of sample. Using a Vitrobot Mark IV (Thermo 585

Fisher Scientific), grids were blotted and plunge-frozen into liquid ethane with 95% 586 chamber humidity at 4°C. 587 588 Cryo-EM data acquisition and processing. Structural biology software was accessed 589 through the SBGrid consortium 35 . The following pertains to each of the respective 590 datasets: 591 S1_RDV-TP: Grids were imaged using a 300 kV Titan Krios (Thermo Fisher Scientific) 592 equipped with a GIF BioQuantum and K3 camera (Gatan). Images were recorded with 593

Leginon 36 with a pixel size of 1.065 Å/px (micrograph dimension of 5760 × 4092 px) 594 over a defocus range of −0.8 μm to −2.5 μm with a 20 eV energy filter slit. Movies were 595 recorded in "counting mode" (native K3 camera binning 2) with ∼25 e-/px/s in dose-596

fractionation mode with subframes of 50 ms over a 2.5 s exposure (50 frames) to give a 597 total dose of ∼54 e-/Å 2 . Dose-fractionated movies were gain-normalized, drift-corrected, 598

summed, and dose-weighted using MotionCor2 37 . The contrast transfer function (CTF) 599

was estimated for each summed image using the Patch CTF module in cryoSPARC 600

v3 . monomer & dimer) were generated using cryoSPARC Ab initio Reconstruction (N=3) on 606 a subset of the particles. Particles were further curated using these initial models as 3D 607

templates for iterative cryoSPARC Heterogeneous Refinement (N=4), resulting in 608 314,848 particles in the monomer class (cyan map, Extended Data Fig. 1 ) and 264,453 609 particles in the dimer class (pink map, Extended Data Fig. 1 ). Curated particles in the 610 monomer and dimer classes were re-extracted to a box size of 384 and input to 611

cryoSPARC Homogenous and Non-uniform refinements 39 . Particles within each class 612

were further processed through two rounds of RELION 3.1 Bayesian Polishing 40 . 613

Polished particles were refined using cryoSPARC Local and Global CTF Refinement in 614 combination with cryoSPARC Non-uniform Refinement, resulting in structures with the 615 following particle counts and nominal resolutions: monomer RTC (251,160 particles; 616

3.54 Å) & dimer RTC (249,468 particles; 3.87 Å). To facilitate model building of the 617 RTC, particles from the dimer RTC class underwent masked particle subtraction in 618 which both protomers were masked, subtracted from the full map, and combined with 619 the original monomer RTC to yield a structure of the RTC at a nominal resolution of 3.38 620 Å from 613,848 particles (Extended Data Fig. 1e ). Local resolution calculations were 621 generated using blocres and blocfilt from the Bsoft package 20 (Extended Data Fig. 1c) .

The angular distribution of particle orientations (Extended Data Fig. 1b) and directional 623 resolution through the 3DFSC package 41 (Extended Data Fig. 1d) were calculated for 624 the final class. 625 S2_ATP: Grids were imaged using a CS corrected 300 kV Titan Krios (Thermo Fisher  626 Scientific) equipped with a GIF BioQuantum and K3 camera (Gatan). Images were 627 recorded with Leginon 36 with a pixel size of 1.076 Å/px (micrograph dimension of 5760 628 × 4092 px) over a defocus range of −0.8 μm to −2.5 μm with a 20 eV energy filter slit. 629

Movies were recorded in "counting mode" (native K3 camera binning 2) with ∼25 e-/px/s 630 in dose-fractionation mode with subframes of 50 ms over a 2.5 s exposure (50 frames) 631

to give a total dose of ∼52 e-/Å 2 . Dose-fractionated movies were gain-normalized, drift-632 corrected, summed, and dose-weighted using MotionCor2 37 . The CTF was estimated 633

for each summed image using the Patch CTF module in cryoSPARC v3.1.0 38 . Particles 634

were picked and extracted from the dose-weighted images with box size of 256 px using 635

cryoSPARC Blob Picker and Particle Extraction. The entire dataset consisted of 11,657 636 motion-corrected images with 5,364,858 particles. Particles were sorted using three 637 rounds of cryoSPARC 2D classification (N=50), resulting in 2,255,856 curated particles. 638

Initial models (denoted as monomer & dimer) were generated using cryoSPARC Ab 639

initio Reconstruction (N=4) on a subset of the particles. Particles were further curated 640 using these initial models as 3D templates for iterative cryoSPARC Heterogeneous 641

Refinement (N=4), resulting in 102,529 particles in the monomer class (cyan map, 642

Extended Data Fig. 2) and 318,672 particles in the dimer class (pink map, Extended 643

Data Fig. 2 ). Curated particles in the monomer and dimer classes were re-extracted to a 644 box size of 384 and input to cryoSPARC Homogenous and Non-uniform refinements 39 . 645

Particles within each class were further processed through two rounds of RELION 3. Initial models (denoted as monomer & dimer) were generated using cryoSPARC Ab 675

initio Reconstruction (N=4) on a subset of the particles. Particles were further curated 676 using these initial models as 3D templates for iterative cryoSPARC Heterogeneous 677

Refinement (N=6), resulting in 648,814 particles in the monomer class (cyan map, 678

Extended Data Fig. 3) and 773,911 particles in the dimer class (pink map, Extended 679 Data Fig. 3 ). Curated particles in the monomer and dimer classes were re-extracted to a 680 box size of 384 and input to cryoSPARC Homogenous and Non-uniform refinements 39 . 681

Particles within each class were further processed through two rounds of RELION 3.1 682

Bayesian Polishing 40 . Polished particles were refined using cryoSPARC Local and 683

Global CTF Refinement in combination with cryoSPARC Non-uniform Refinement, 684

resulting in structures with the following particle counts and nominal resolutions: Fig. 3c ). The angular distribution of particle 695 orientations (Extended Data Fig. 3b ) and directional resolution through the 3DFSC 696 package 41 (Extended Data Fig. 3d) were calculated for the final class. 697 S4_GTP: Grids were imaged using a CS corrected 300 kV Titan Krios (Thermo Fisher 698

Scientific) equipped with a GIF BioQuantum and K3 camera (Gatan). Images were 699 recorded with SerialEM 43 with a pixel size of 1.08 Å/px (micrograph dimension of 5760 700 × 4092 px) over a defocus range of −0.8 μm to −3.0 μm with a 20 eV energy filter slit. 701

Movies were recorded in "counting mode" (native K3 camera binning 2) with ∼25 e-/px/s 702 in dose-fractionation mode with subframes of 50 ms over a 2.5 s exposure (50 frames) 703

to give a total dose of ∼51 e-/Å 2 . Dose-fractionated movies were gain-normalized, drift-704 corrected, summed, and dose-weighted using MotionCor2 37 . The CTF was estimated 705

for each summed image using the Patch CTF module in cryoSPARC v3. Fig. 4e ). Local resolution calculations were generated using 721 blocres and blocfilt from the Bsoft package 20 (Extended Data Fig. 4c ). The angular 722 distribution of particle orientations (Extended Data Fig. 4b ) and directional resolution 723 through the 3DFSC package 41 (Extended Data Fig. 4d) Fig. 5e ). This combined RTC class was further refined with masked cryoSPARC 756

Local Refinement using masks around the RdRp and NiRAN active sites. Locally 757 refined maps were combined into a RTC composite map using PHENIX 'Combine 758

Focused Maps' to aid model building 42 . Local resolution calculations were generated 759 using blocres and blocfilt from the Bsoft package 20 (Extended Data Fig. 5c ). The 760 angular distribution of particle orientations (Extended Data Fig. 5b ) and directional 761 resolution through the 3DFSC package 41 (Extended Data Fig. 5d ) are shown for the 762 final class. 763 nM RNA scaffold, 0.75 µM nsp12, 2 µM nsp7/8 and NTPs 300 µM (if present as natural 809

nucleotides, NDPs or α-β analogues) and 1 µL α-32 P-GTP (Perkin-Elmer) were 810 incubated at 30 o C for 10 minutes prior to addition of a 2x stop solution (Invitrogen-Gel 811

Loading buffer II). Assay buffer was 100 mM K-acetate, 20 mM HEPES pH 8.0, 5 mM 812

MgCl2 & 2 mM BME in which the MgCl2 was substituted with CaCl2 when monitoring the 813 effects of alternative metal ions. Products of the elongation reactions were separated on 814

10% acrylamide-8M urea denaturing gels and analyzed by phosphorimaging. 

Extended Data Fig 1. (a) Cryo-EM processing pipeline for the S1_RDV-TP dataset

Scale 898 depicts number of particles assigned to a specific angular bin. (c) Nominal 3.38Å 899 resolution cryo-EM reconstruction filtered by local resolution and colored according to 900 fitted model chain. Right panel is clipped to reveal RTC active site. (d) Directional 3D 901 FSC for S1_RDV-TP, determined with 3DFSC. (e) Gold-standard FSC plot for the 902 S1_RDV-TP dataset, calculated by comparing two half maps from cryoSPARC

Extended Data Fig 2. (a) Cryo-EM processing pipeline for the S2_ATP dataset

Scale 907 depicts number of particles assigned to a specific angular bin. (c) Nominal 3.09Å 908 resolution cryo-EM reconstruction filtered by local resolution and colored according to 909 fitted model chain. Right panel is clipped to reveal RTC active site. (d) Directional 3D 910 FSC for S2_ATP, determined with 3DFSC. (e) Gold-standard FSC plot for the S2_ATP 911 dataset, calculated by comparing two half maps from cryoSPARC

Extended Data Fig 3. (a) Cryo-EM processing pipeline for the S3_UTP dataset

Scale 916 depicts number of particles assigned to a specific angular bin. (c) Nominal 3.13Å 917 resolution cryo-EM reconstruction filtered by local resolution and colored according to 918 fitted model chain. Right panel is clipped to reveal RTC active site. (d) Directional 3D 919 FSC for S3_UTP, determined with 3DFSC. (e) Gold-standard FSC plot for the S3_UTP 920 dataset, calculated by comparing two half maps from cryoSPARC

Extended Data Fig 5. (a) Cryo-EM processing pipeline for the S5_CTP dataset

Scale 934 depicts number of particles assigned to a specific angular bin. (c) Nominal 2.67Å 935 resolution cryo-EM reconstruction filtered by local resolution and colored according to 936 fitted model chain. Right panel is clipped to reveal RTC active site. (d) Directional 3D 937 FSC for S5_CTP, determined with 3DFSC. (e) Gold-standard FSC plot for the S5_CTP 938 dataset, calculated by comparing two half maps from cryoSPARC

Analysis of a representative MS spectrum (sample: RTC + 962 RDV-TP) is shown. (b) The table of native MS mass measurements obtained from 963 UniDec deconvolution of the RTC and RTC* samples used in the NTP incorporation

Zoom-in on the active site of S4_GTP, highlighting residues 975 (sticks) which interact with the bound GTP/2xMg in which ribbon/sticks are colored 976 according to the amino acid conservation across a representative list of viruses found in 977 the α & β coronavirus clades (Supplementary information). (b) Bar plot showing the 978 frequency of occurrence of the wild-type amino acid

/2019) as well as their summed mutations according to the GISAID database

for the nsp12 active site residues and the nsp12 residue P323. (c) Bar plot 981 showing the frequency of occurrence of the wild-type amino acid

/2019) as well as their summed mutations according to the GISAID 983 database

Analysis of the active sites of structures (S1-S5) illustrate 988 that K545 and R555 interact differentially with each of the incoming nucleotides. H-989 bonds are depicted as dotted-cyan lines. (f, g) 2D schematics illustrating the set of 990 interactions between RDV-TP (f) and ATP (g) and the active site

Base-out' pose. (b) Models (PDBs 7ED5 & 7UOB) of the nsp12 996 NiRAN with a bound base in the 'Base-in' pose. (c) Surface representation detailing the 997 NiRAN active site pocket bound to a nucleotide in the 'base-out' pose (PDB 6XEZ) 998 aligned with a structure

discussions. Some of the work reported here was conducted at the Simons Electron

Model building and refinement. An initial model of the RTC was derived from PDB 765 7RE1 17 . The models were manually fit into the cryo-EM density maps using Chimera 44 766 and rigid-body and real-space refined using Phenix real-space-refine 42 . For real-space 767 refinement, rigid body refinement was followed by all-atom and B-factor refinement with 768Ramachandran and secondary structure restraints. Models were inspected and 769 modified in Coot 0.9.5 45 and the refinement process was repeated iteratively. 770 771 Native mass spectrometry (nMS) analysis. The RTC samples were initially 772 reconstituted as described above in the following buffer: 20 mM HEPES pH 8. In-vitro primer elongation assays. Assays were performed using reconstituted 806 template-primer RNA scaffolds (Table S1)